Who We Are: Our Mission at Wu Consulting Group


‍

Biometrics support that gives clinical teams confidence

Wu Consulting started 30 years ago to do one thing well: provide highly experienced biostatisticians, statistical programmers and clinical data managers who produce high-quality results with minimal hand-holding.
Academic pedigrees
15 years average experience
1-week onboarding
Local resources, globally
95% have advanced degrees
FSP and project-based models

Working together with you on your biometrics program from start to finish

Clarity
Together we define what success looks like for you
Accountability
Everyone on our team knows your context and their role
Quick Integration
We get up to speed quickly based on clarity and experience
Results
Delivering quality work that moves your project forward

Leadership Team:


Wei is the Founder and President of Wu Consulting, dedicating his career to supporting sponsors and their biometrics teams.

He holds a BE in Electrical Engineering from Tianjin University and an MA in Demography from Georgetown University.
Wei Zhang
Founder

Steven has extensive experience leading global programming and data science teams to improve efficiency, reduce costs, and enable innovation.

He holds a BA in Mathematical Statistics and Probability from Harvard College and an MBA from Harvard Business School.
Steven Tan
CEO

Ken brings deep business development expertise, helping biotech and pharma organizations rapidly scale biometrics teams and secure top talent.

He holds a BS in Economics from the University of Maryland and a degree in Clinical Trials Management and Regulatory Compliance from the University of Chicago.
Kenneth Roby
Sr. Director of Business Development

Jordan is a veteran life sciences recruiter who brings expertise in biometrics, clinical development, andregulatory talent acquisition across pharma, biotech, and CRO organizations.

He holds a BA from Columbia CollegeChicago in Fine Studio Arts.
Jordan Searce
Sr. Director of Talent Acquisition

Brian has spent his career in clinical data science, leading teams that build agentic AI systems to automate CDISC delivery regulatory submissions for top-tier pharma clients.

He holds a MPH in Epidemiology from Georgia State University.
Brian Carter
Director of Innovation

Sherry has led global oncology and neuroscience programs at AstraZeneca, Taiho Oncology, and Mitsubishi Tanabe. She specializes in adaptive and seamless trial designs, dose optimization, and has supported submissions with the FDA, EMA, MHRA, and PMDA.  

She holds a PhD in Statistics from Temple University.
Sherry Liu
Head of Biostatistics